Orthopaedic Oncology Market Growth and Forecast 2015-2025
Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a condition that arises due to the formation of benign and malignant tumors in bones and connective soft tissues. It also includes the diagnosis and treatment of patients with metastatic carcinomato the skeleton. Bone and soft tissue tumors are quite rare and sometimes require reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas. For 2016, the American Cancer Society estimates about 3,300 new cases for cancer of the bones and joints and 12,310 new cases for soft tissue sarcomas.
Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a condition that arises due to the formation of benign and malignant tumors in bones and connective soft tissues. It also includes the diagnosis and treatment of patients with metastatic carcinomato the skeleton. Bone and soft tissue tumors are quite rare and sometimes require reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas. For 2016, the American Cancer Society estimates about 3,300 new cases for cancer of the bones and joints and 12,310 new cases for soft tissue sarcomas.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Global <strong>Orthopaedic</strong><br />
<strong>Oncology</strong> <strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> <strong>Forecast</strong>,<br />
2016 – 2026<br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Report Description<br />
Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a<br />
condition that arises due to the formation of benign <strong>and</strong> malignant tumors in bones <strong>and</strong><br />
connective soft tissues. It also includes the diagnosis <strong>and</strong> treatment of patients with metastatic<br />
carcinomato the skeleton. Bone <strong>and</strong> soft tissue tumors are quite rare <strong>and</strong> sometimes require<br />
reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas. For 2016,<br />
the American Cancer Society estimates about 3,300 new cases for cancer of the bones <strong>and</strong> joints<br />
<strong>and</strong> 12,310 new cases for soft tissue sarcomas. There are three main types of bone cancers,<br />
osteosarcoma, which arises most often in the growing ends of long bones, chondrosarcoma,<br />
which develops in the metaphysis <strong>and</strong> Ewing’s sarcoma. Malignant bone tumors also referred to<br />
as chondrosarcoma are more prevalent in adults than other form of cancers <strong>and</strong> remains a<br />
challenging tumor to diagnose <strong>and</strong> treat. Treatment with chemotherapy <strong>and</strong> radiotherapy do<br />
not remain the preferred choice of treatment in treating such type of tumor as clinical studies<br />
demonstrate no substantial improvements in the survival rate of the patients. Therefore,<br />
adequate surgical resection is the mainstay of treatment in case of chondrosarcoma. As<br />
estimated by the American Cancer Society, chondrosarcomas is more prevalent with 40% of<br />
cases developing in adults whereas less than 5% of cases occur in patients younger than 20.<br />
Radiofrequency ablation has become the st<strong>and</strong>ard <strong>and</strong> most preferred choice of treatment in<br />
case of osteoid osteoma, a benign bone tumor that arises from osteoblasts. However studies<br />
demonstrates its exp<strong>and</strong>ed application in palliative treatment of patients with painful bone<br />
metastasis.
Report Description<br />
The ability to perform less invasive procedures often allows more efficient, less painful, <strong>and</strong><br />
more cost-effective patient care. In addition, minimally invasive techniques such as kyphoplasty,<br />
vertebroplasty, <strong>and</strong> acetabuloplasty may provide an alternative to major reconstructive surgery<br />
for patients with metastatic disease.<br />
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-<br />
1523<br />
Global <strong>Orthopaedic</strong> <strong>Oncology</strong> <strong>Market</strong>: Drivers & Restraints<br />
Factors driving the global orthopedic oncology market includes rapidly ageing population with<br />
increasing risk of developing cancer. Patients who had prior high-dose external radiation therapy<br />
or treatment with anti-cancer drugs are at higher risk of developing osteosarcoma. However, a<br />
small number of bone cancers also develop due to heredity defects of bones <strong>and</strong> people with<br />
metal implants, which doctors sometimes use to repair fractures, are more likely to develop<br />
osteosarcoma. In case of soft tissue sarcoma adults with heredity disorders such as<br />
retinoblastoma, tuberous sclerosis, werner syndrome etc are at higher side of developing this<br />
type of cancer.<br />
High cost associated with the treatment for musculoskeletal oncology diseases <strong>and</strong> lack of<br />
awareness regarding the effective treatment therapies are some of the factors which restraint<br />
the market growth in the near future
Report Description<br />
Global <strong>Orthopaedic</strong> <strong>Oncology</strong> <strong>Market</strong>: Segmentation<br />
Orthopedic <strong>Oncology</strong> market is segmented by treatment, by end user <strong>and</strong> geography:<br />
By Treatment<br />
• Surgery<br />
• Amputation<br />
• Limb Salvage Surgery<br />
• Reconstructive Surgery<br />
• Chemotherapy<br />
• Radiation Therapy<br />
• Targeted Therapy<br />
By End User<br />
• Multispecialty Hospitals<br />
• Cancer Research Institutes<br />
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1523<br />
Global <strong>Orthopaedic</strong> <strong>Oncology</strong> <strong>Market</strong>: Overview<br />
Rising prevalence of musculoskeletal disorders are expected to drive the dem<strong>and</strong> for effective<br />
treatment therapies for treatment of various cancers associated with bones <strong>and</strong> soft tissues. The<br />
orthopaedic oncology market is expected to grow at a healthy pace attributed to rising<br />
prevalence of cancer over the forecasted period.
Report Description<br />
Global <strong>Orthopaedic</strong> <strong>Oncology</strong> <strong>Market</strong>: Region-wise Outlook<br />
On the basis of region presence, thrombophilia treatment market is segmented into seven key<br />
regions: North America, Latin America, <strong>and</strong> Eastern Europe, Western Europe, <strong>and</strong> Asia pacific<br />
excluding japan, Japan, Middle East <strong>and</strong> Africa. Global market for Orthopediac oncology is<br />
expected to be on a higher side in North America <strong>and</strong> Europe owing to increasing prevalence of<br />
cancer <strong>and</strong> musculoskeletal related disorders. Asia pacific represents immense growth<br />
opportunity for orthopedic oncology market attributed to rapidly aging population <strong>and</strong> rising<br />
cancer incidence. In addition macroeconomic factors such as FDA approvals are also expected to<br />
increase the adoption rate of devices in the developed countries.<br />
Discussion With Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1523<br />
Global <strong>Orthopaedic</strong> <strong>Oncology</strong> <strong>Market</strong>: Key Players<br />
Some of the key market players in the orthopedic oncology market are Stryker Corporation,<br />
Accentus Inc., Roche Diagnostics, Amgen Inc., Novartis AG, Biogen Idec, GlaxoSmithKline, Sanofi<br />
S.A., <strong>and</strong> Pfizer Inc.
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <strong>and</strong> consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.<br />
We combine our knowledge <strong>and</strong> learning from every corner of the world to distill it to one thing – the perfect solution for<br />
our client.<br />
Research<br />
Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Subscription Information<br />
Sector Coverage<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
• Automotive <strong>and</strong> Transportation<br />
• Chemicals & Materials<br />
• Electronics, Semiconductor, <strong>and</strong> ICT • Food <strong>and</strong> Beverages<br />
• Retail <strong>and</strong> Consumer Products<br />
• Services <strong>and</strong> Utilities<br />
• Industrial Automation <strong>and</strong> Equipment • Energy, Mining, Oil, <strong>and</strong><br />
• Healthcare, Pharmaceuticals & Medical Devices Gas
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For other queries contact:<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705